A patient with both Gilles de la Tourette's syndrome and chromosome 22q11 deletion syndrome: clue to the genetics of Gilles de la Tourette's syndrome?

Journal of Psychosomatic Research

Volumn 61, Issue 3, 2006, Pages 365-368

  Robertson, Mary M ^a,b   Shelley, Bhaskara Pillai ^b,c   Dalwai, Suraiya ^d   Brewer, Carole ^e   Critchley, Hugo D ^d  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c ROYAL HOSPITAL   (Oman)

^d The National Hospital   (United Kingdom)

^e Royal Exeter and Devon Hospital   (United Kingdom)

Author keywords

CATCH 22 syndrome; Chromosome 22q11.2 deletion syndrome; Endophenotype; Genetics; Gilles de la Tourette's syndrome; Microdeletion syndrome

Indexed keywords

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CHROMOSOME DELETION; CLINICAL FEATURE; CYTOGENETICS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FAMILY HISTORY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC ANALYSIS; GILLES DE LA TOURETTE SYNDROME; HUMAN; QUANTITATIVE TRAIT LOCUS;

ADULT; ASPERGER SYNDROME; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BRAIN; CHROMOSOMES, HUMAN, PAIR 22; FEMALE; GENE DELETION; HUMANS; OBSESSIVE-COMPULSIVE DISORDER; PSYCHOMOTOR DISORDERS; TOURETTE SYNDROME;

EID: 33747820896     PISSN: 00223999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2006.06.011     Document Type: Article

References (28)

1. Robertson M. The heterogenous psychopathology of Tourette syndrome. In: Bedard M., Agid Y., Chouinard S., Fahn S., Korczyn A., and Lesperance P. (Eds). Mental and behavioural dysfunction in movement disorders (2003), Humana Press, Totowa (NJ) 443-465
2. Robertson M. Invited review. Tourette syndrome associated conditions and the complexities of treatment. Brain 123 (2000) 425-462
3. Leckman J. Tourette's syndrome. Lancet 360 (2002) 1577-1586
4. Singer H. Tourette's syndrome: from behaviour to biology. Lancet Neurol 4 (2005) 149-159
5. Robertson M. Tourette syndrome. Psychiatry 4 (2005) 92-97
6. Pauls D. Update on the genetics of Tourette syndrome. In: Cohen D., Jankovic K., and Goetz C. (Eds). Advances in neurology vol. 85 (2002), Lippincott Williams and Wilkins, Philadelphia (Pa) 281-293
7. Pauls D. An update on the genetics of Gilles de la Tourette syndrome. J Psychosom Res 55 (2003) 7-12
8. Wilson D., Burn J., Scrambler P., and Goodship J. DiGeorge syndrome: part of CATCH 22. J Med Genet 30 (1993) 852-856
9. Papolos D., Gianni F., Veit S., et al. Bipolar spectrum disorders in patients diagnosed with velo-cardiofacial syndrome: does a hemizygous deletion of chromosome 22q11 result in bipolar affective disorder?. Am J Psychiatry 153 (1996) 1541-1547
10. Gothelf D., and Lombrosso P. Velocardiofacial syndrome. J Am Acad Child Adolesc Psychiatry 40 (2001) 489-491
11. Feinstein C., and Eliez S. The velocardiofacial syndrome in psychiatry. Curr Opin Psychiatry 13 (2000) 485-490
12. Gothelf D., Presburger G., Zohar A., Burg M., Nahmani A., Frydman M., Shohat M., Inbar D., Aviram-Goldring A., Yeshava J., Steinberg T., Finkelstein Y., Frisch A., Weizman A., and Apter A. Obsessive-compulsive disorder in patients with velocardiofacial (22q11 deletion) syndrome. Am J Med Genet B Neuropsychiatr Genet 126 (2004) 99-105
13. Gothelf D., Presburger G., Levy D., Nahmani A., Burg M., Berant M., Blieden L., Finkelstein Y., Frisch A., Apter A., and Weizman A. Genetic, developmental, and physical factors associated with attention deficit hyperactivity disorder in patients with velocardiofacial syndrome. Am J Med Genet B Neuropsychiatr Genet 126 (2004) 116-121
14. Antshel K., Conchelos J., Lanzetta G., Fremont W., and Kates W. Behaviour and corpus callosum morphology relationships in velocardiofacial syndrome (22q112 deletion syndrome). Psychiatry Res 138 (2005) 235-245
15. Moriarty J., Varma A., Stevens J., Fish M., Trimble M., and Robertson M. A volumetric MRI study of Gilles de la Tourette's syndrome. Neurology 49 (1997) 410-415
16. Mostofsky S., Wendlandt J., Cutting L., Denckla M., and Singer H. Corpus callosum measurements in girls with Tourette syndrome. Neurology 53 (1999) 1345-1347
17. Gottesman I., and Gould T. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 160 (2003) 636-645
18. Inoue K., and Lupski J. Genetics and genomics of behavioural and psychiatric disorders. Curr Opin Genet Dev 13 (2003) 303-309
19. Bender H., Almashanu S., Steel G., Hu C., Lin W., Willis A., Pulver A., and Valle D. Functional consequences of PRODH missense mutations. Am J Hum Genet 76 (2005) 409-420
20. Kunugi H., Vallada H., Sham P., et al. Catechol-O-methyltransferase polymorphisms and schizophrenia: a transmission disequilibrium study in multiple affected families. Psychiatr Genet 7 (1997) 97-101
21. Strous R., Bark N., Parsia S., et al. Analysis of a functional catechol-O-methyltransferase gene polymorphism in schizophrenia: evidence for association with aggressive and antisocial behaviour. Psychiatr Res 69 (1997) 71-77
22. Papolos D., Veit S., Faedda G., et al. Ultra-ultra rapid cycling bipolar disorder is associated with the low activity catechol-O-methyltransferase allele. Mol Psychiatry 3 (1998) 346-349
23. Kirov G., Murphy K., Arranz M., et al. Low activity allele of catechol-O-methyltransferase gene associated with rapid cycling bipolar disorder. Mol Psychiatry 3 (1998) 342-345
24. Karayiorgou M., Altemus M., Galke B., Goldman D., Murphy D., Ott J., and Gogos J. Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorder. Proc Natl Acad Sci U S A 94 (1997) 4572-4575
25. Karayiorgou M., Sobin C., Blundell M., Galke B., Malinova L., Goldberg P., Ott J., and Gogos J. Family based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive-compulsive disorder. Biol Psychiatry 45 (1999) 1178-1189
26. Alsobrook J., Zohar A., Leboyer M., Chabane N., Ebstein R., and Pauls D. Association between the COMT locus and obsessive-compulsive disorder in females but not males. Am J Med Genet 114 (2002) 116-120
27. Eisenberg J., Mei-Tal G., Steinberg A., Tartakovsky E., Zohar A., Gritsenko I., Nemanov L., and Ebstein R. Haplotype relative risk study of catechol-O-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD): association of the high-enzyme activity Val allele with ADHD impulsive-hyperactive phenotype. Am J Med Genet 88 (1999) 497-502
28. Lachman H., Papolos D., Saito T., Yu Y., Szumlanski C., and Weinshilboum R. Human catechol-O-methlytransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6 (1996) 243-250